Clinical Trial Update: Effects of Metformin vs Oral Contraceptives on CV Risk Markers in PCOS [Phase 4]

View source ↗

Summary

Phase 4 trial comparing metformin versus combined oral contraceptives for cardiovascular risk markers in polycystic ovary syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• Combined oral contraceptives
• metformin (metformin)

Snippet

Sponsor: Hospital Universitario Ramon y Cajal | Conditions: Polycystic Ovary Syndrome | Phase 4 | Status: COMPLETED